Regulatory
Pharma Pricing is Top Target for Medicare Cutbacks
In the dog-eat-dog world of federal deficit reduction, there seems to be one health-related spending cut with broad bi-partisan support: require drug companies to give the federal government “a better deal on medications for low-income people on Medicare” ...Read more
Event
Five Compliance Questions to Ask Yourself, from the DOJ
At CBI's 10th Annual Pharmaceutical Compliance Congress, Maame Ewusi-Mensah Frimpong, deputy assistant attorney general, consumer protection branch, civil division, at the US Department of Justice, said being compliant means understanding people, and their motivations. Frimpong said non-compliance boils down to a failure of individuals, and offered five questions for chief compliance officers to ask themselves about their colleagues ...Read More
IP
The Strange Twists and Turns of ‘Pay for Delay’
In the arcane world of patent litigation, the term ‘pay for delay’ can be misleading, and as the Washington debate to restrict these deals unfolds, it is becoming apparent that a ban on such settlements may serve to delay generics even further. Is the fresh grass of reform really always greener than the well-seeded status quo? ...Read more
World Health
Banning Thimerosal in Vaccines 'Would be a Tragedy'
Public health authorities and medical experts have challenged a provision blocking production of vaccines with the preservative thimerosal, the formulation necessary for efficient vaccine distribution in developing countries. Banning thimerosal “would be a tragedy” that puts millions of children at risk, according to the Global Alliance for Vaccines & Immunization ...Read more
Video
Amid Flu Epidemic, Pharma Innovating on Vaccines
As flu infections reach epidemic levels across the US, new innovations are coming soon in the influenza vaccine market ...Read more
Emerging Markets
Who Lost Syria?
In the wake of the Syrian humanitarian crisis, Clark Herman looks at what Big Pharma can do to gradually restore a presence in the market ...Read more
Global
Read the New Pharm Exec Global Digest
In the January 2013 issue: What Now for Greece? — Brazil’s War on AIDS — The African Markets Pharma Can’t Ignore — and Global Safety and Harmonization Efforts 2013 ...Read more
|
